I believe that CRSP (Crispr Therapeutics) is about to undergo a severe correction soon. I scaled into this stock during the latter part of 2022 and the first part of 2023 and it is up nearly 70% and has generated about 40% of pure alpha for me relative to the SPX. So this has been an amazing performer for my total portfolio. I believe this run may be nearing a...
Looking for calls on CRSPR around the 45ish levels. Very bullish on this company and from what I can tell we may be able to even buy some call options now but odds are IMO we will re test the 45ish price levels and then BOOM expand to the upside.
CRSP Looking to break out of triangle formation. Tight stop is possible at 71.90.
CRSP broke its trend line to the downside coming out of a head and shoulder pattern, has a bullish regular divergence. There is chance to broke to the next level of $80 where it has found resistance in the past, but divergence indicates that it probably continue to consolidating and then broke to the upside. It has found resistance at these levels in the past more...
Youtube FLASH INSTINCTS for more content and thanks for support.
Here is my follow up update on original CRSP swing short trade idea I put up on January 14th. On this post, I am zooming out to weekly chart, looking at longer time frame to capture cyclical trends. Going back all the way to 2017 inception period, the higher than average volatilities are pretty easy to notice. It moves up really fast but also coming down. Every...
Technical Analysis Since early December, we have had over a dozen tails on the purple up-trend arrow drawn in. The 50sma is now coming into play, as a break below that, could take us another 20% down to the 100sma. An appropriate level to exit the trade then, would be below the 50sma. There also horizontal support as we fill the gap. Important Note:...
Indicators and wave count pointing toward a reversal SOON. Monitor price action
Here is the updated chart on CRSP short trade I posted on January 14th. It's been down 23% since the date it was posted. So far so good. First target was hit today and managed to keep above as I have expected. I expect more downside in days to come. XBI sector can break down anytime too now. Literally one red day will do. My next target is the bottom of the...
CRSP is the leader and pioneer of the CRISPR/CAS9 gene-editing breakthrough. It is a long-term bet as short-term to mid-term future is uncertain. I think it has one more leg down. Accumulate in the demand zone.
One to watch. If it can clear out of this resistance area this week or next, it could do really well for awhile. Otherwise, wait for fall back to trendline.
Considering the fib relations (not shown) this is my most likely count. If the upper horizontal line gets crashed, the sky is the limit.
In my previous post on #CRISPR I talked about the Green upward sloping trendline & how every time CRSPR has traded on or below it since May 2017 we've seen parabolic action. I don't want to say I told you so, but we've seen some parabolic action. To my surprise, the parabolic movement came the news of Vertex upfront payment of $175 million upfront payment....
Since July 2017, every time CRSP has traded on or below the Green upward sloping trendline CRSP has seen some parabolic action. Time will tell per usual.
long CRSP accumulation to shoulder break headed to neckline
Technical breakdown of CRISPR gene editing with ya boy Meteor Hammer, First off, This technology really will change the future and these are the pioneers. could potentially end all disease and cure cancer, think about it... Amazing and spooky shit ladies and gentlemen. This chart looks great. Price just broke through a critical line, and re-entered what could...
The uprise is overheated an is loosing momentum. One more push to the upside (a wave b of the present abc correction) will complete the "three pushes " series, in which the upthrust above the upper Keltner channel border decreases continuously. Afterwards, a fall to the lowest trendline is possible. After that, a sharp ascent to the highest trendline is likely.